September 28, 2020
⚡️🇺🇸#MTD #отчетность
Medtronic
Q4 Revenue of $8.2 Billion Increased 37% Reported and 32% Organic
- Q4 GAAP Diluted EPS of $1.00; Q4 Non-GAAP Diluted EPS of $1.50
- Quarterly Dividend Increased to $0.63, Annual $2.52 from Prior $2.32; 44th Consecutive Year of Dividend Increases #дивиденд
#прогноз Guidance Reflects FY22 Revenue Growth above Street Consensus, Investment Ahead of Major Product Launches, and Largest Planned R&D Increase in Company History
Medtronic
Q4 Revenue of $8.2 Billion Increased 37% Reported and 32% Organic
- Q4 GAAP Diluted EPS of $1.00; Q4 Non-GAAP Diluted EPS of $1.50
- Quarterly Dividend Increased to $0.63, Annual $2.52 from Prior $2.32; 44th Consecutive Year of Dividend Increases #дивиденд
#прогноз Guidance Reflects FY22 Revenue Growth above Street Consensus, Investment Ahead of Major Product Launches, and Largest Planned R&D Increase in Company History
May 27, 2021
August 6, 2021